Gene · 640
NIH grants1,820
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,820
Download this page as JSON| Grant | Title | BLK papers | Newest fiscal year |
|---|---|---|---|
| R01AG082118 | Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches | 1 | 2025 |
| R01AG084250 | Microglial Activation and Inflammatory Endophenotypes Underlying Sex Differences of Alzheimer’s Disease | 1 | 2025 |
| R01AI049954 | Gene Transcription in SLE | 1 | 2025 |
| R01AI085567 | Expanded Double Negative T cells in SLE. | 1 | 2025 |
| R01AI114780 | Mechanisms of autoimmunity in myasthenia gravis | 1 | 2025 |
| R01AI127372 | Human ISG15 and USP18 Deficiencies Underlying Type I Interferonopathies | 1 | 2025 |
| R01AI162971 | IRF7-mediated development of autoreactive B cells and SLE | 1 | 2025 |
| R01AI163029 | Inborn errors of immunity in patients with life-threatening COVID-19 | 1 | 2025 |
| R01AR073111 | The Pregnancy Transcriptome in Rheumatoid Arthritis - Renewal | 1 | 2025 |
| R01AR073201 | Bridging the gap between GWAS and mechanism in arthritis | 1 | 2025 |
| R01AR075813 | Impact of Loss-of-function NADPH Oxidase Variants on B cell Activation in SLE | 1 | 2025 |
| R01AR078785 | Epigenetic Mechanisms That Drive Genetic Risk in Juvenile Arthritis | 1 | 2025 |
| R01CA085862 | Adhesive regulation during cell migration | 1 | 2025 |
| R01CA166835 | Targeted therapy for t(8;21)+ AML | 1 | 2025 |
| R01CA174869 | Regulation of Tumor Invasion and Metastasis by Matrix Stiffness | 1 | 2025 |
| R01CA246133 | Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis | 1 | 2025 |
| R01CA248080 | Neutral sphingomyelinase-2 as a mediator of Doxorubicin-induced cardiotoxicity | 1 | 2025 |
| R01CA256188 | Probing cytosolic nucleic acid sensing pathways in cancer | 1 | 2025 |
| R01CA262090 | Programmed splicing derangement as new EBV host cell shut-off mechanism | 1 | 2025 |
| R01CA262758 | Mechanisms of venetoclax combination activity in acute myeloid leukemia | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/grants?page=8